Apollo Global Management, Inc. Form 8-K Summary
Business context and reporting period
Apollo Global Management, Inc. filed a Form 8-K reporting an unregistered equity issuance connected with a strategic arrangement. The reported event occurred on February 15, 2022; the filing was signed on February 22, 2022. The filing does not provide a financial reporting period or financial statements.
Key financial and capital markets information
- On February 15, 2022, Apollo issued five warrants to an institutional investor in a private placement relying on Section 4(a)(2) of the Securities Act.
- Each warrant is exercisable for 2.6 million shares of common stock at an exercise price of $82.80 per share, representing up to 13.0 million underlying shares in aggregate before anti-dilution adjustments.
- Each warrant is settled on a cashless net exercise basis; the filing does not state expected cash proceeds from exercise.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating-financial metrics.
Material changes, outlook, and risks
- The first warrant was exercisable beginning on the issuance date. Subject to specified exceptions, the remaining warrants become exercisable on the first, second, third, and fourth anniversaries of issuance.
- The warrants expire on the fifth anniversary of issuance. Vested but unexercised warrants are automatically exercised at expiration if Apollo’s trading price is above the exercise price.
- The underlying share count and exercise price are subject to customary anti-dilution adjustments, including adjustments for stock splits, certain dividends or distributions, and specified corporate events.
- The principal investor consideration is potential future dilution of existing common stockholders. The filing does not describe the broader strategic arrangement, management guidance, or other contingencies.
Investor verification points
- Verify the terms and economic purpose of the strategic arrangement, which are not described in the filing text.
- Verify the current status, vesting, exercise, and expiration of each warrant.
- Assess potential dilution from up to 13.0 million underlying shares, subject to anti-dilution adjustments and cashless exercise mechanics.
- Review subsequent filings for warrant exercises, share-count changes, or additional disclosures regarding the arrangement.